Published by
@ShahidNShah
@ShahidNShah
The 6th Targeted Radiopharmaceuticals Summit Europe is held on 03-05 December 2024 in Amsterdam,Europe**.**This year has been the year for radiopharmaceuticals, with market projections estimating to grow to $39 billion by 2032. More patients are being treated by Pluvicto and Lutathera than ever before, companies advancing their pipelines across a range of targeting moieties, radioisotopes and novel targets including DLL3 and NTSR1- and that's not to mention the flood of billion-dollar acquisitions and investments from Novartis, AstraZeneca, Eli Lilly and BMS strengthening the field! The 6th Targeted Radiopharmaceuticals Summit Europe is the longest standing industry focused meeting delivering an end-to-end overview of this highly competitive and dynamic landscape.
[Read on targeted-radiopharma.com](https://targeted-radiopharma.com/take-part/register/)
Continue reading at targeted-radiopharma.com
December 3 to December 5, 2024
Hyatt Regency Boston, One Avenue de Lafayette, Boston, Massachusetts, 02111, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Sep 13, 2024 at 11:52am